High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

<h4>Background</h4> <p>Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccha...

Full description

Bibliographic Details
Main Authors: O'Connor, D, Clutterbuck, E, Thompson, A, Snape, M, Ramasamy, M, Kelly, D, Pollard, A
Format: Journal article
Language:English
Published: BioMed Central 2017
_version_ 1797051692344147968
author O'Connor, D
Clutterbuck, E
Thompson, A
Snape, M
Ramasamy, M
Kelly, D
Pollard, A
author_facet O'Connor, D
Clutterbuck, E
Thompson, A
Snape, M
Ramasamy, M
Kelly, D
Pollard, A
author_sort O'Connor, D
collection OXFORD
description <h4>Background</h4> <p>Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccharide conjugate vaccines. Here we apply contemporary methods to describe B-cell responses to meningococcal polysaccharide and conjugate vaccines.</p> <h4>Methods</h4> <p>Twenty adults were randomly assigned to receive either a meningococcal plain-polysaccharide or conjugate vaccine; one month later all received the conjugate vaccine. Blood samples were taken pre-vaccination and 7, 21 and 28 days after vaccination; B-cell responses were assessed by ELISpot, serum bactericidal assay, flow cytometry and gene expression microarray.</p> <h4>Results</h4> <p>Seven days after an initial dose of either vaccine, a gene expression signature characteristic of plasmablasts was detectable. The frequency of newly generated plasma cells (CXCR3+HLA-DR+) and the expression of transcripts derived from IGKC and IGHG2 correlated with immunogenicity. Notably, using an independent dataset, the expression of glucosamine (N-acetyl)-6-sulfatase was found to reproducibly correlate with the magnitude of immune response. Transcriptomic and flow cytometric data revealed depletion of switched memory B cells following plain-polysaccharide vaccine.</p> <h4>Conclusions</h4> <p>These data describe distinct gene signatures associated with the production of high-avidity antibody and a plain-polysaccharide-specific signature, possibly linked to polysaccharide-induced hyporesponsiveness.</p>
first_indexed 2024-03-06T18:23:08Z
format Journal article
id oxford-uuid:070022b5-4ccc-4764-98ee-a944bc66010a
institution University of Oxford
language English
last_indexed 2024-03-06T18:23:08Z
publishDate 2017
publisher BioMed Central
record_format dspace
spelling oxford-uuid:070022b5-4ccc-4764-98ee-a944bc66010a2022-03-26T09:05:23ZHigh-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:070022b5-4ccc-4764-98ee-a944bc66010aEnglishSymplectic Elements at OxfordBioMed Central2017O'Connor, DClutterbuck, EThompson, ASnape, MRamasamy, MKelly, DPollard, A <h4>Background</h4> <p>Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccharide conjugate vaccines. Here we apply contemporary methods to describe B-cell responses to meningococcal polysaccharide and conjugate vaccines.</p> <h4>Methods</h4> <p>Twenty adults were randomly assigned to receive either a meningococcal plain-polysaccharide or conjugate vaccine; one month later all received the conjugate vaccine. Blood samples were taken pre-vaccination and 7, 21 and 28 days after vaccination; B-cell responses were assessed by ELISpot, serum bactericidal assay, flow cytometry and gene expression microarray.</p> <h4>Results</h4> <p>Seven days after an initial dose of either vaccine, a gene expression signature characteristic of plasmablasts was detectable. The frequency of newly generated plasma cells (CXCR3+HLA-DR+) and the expression of transcripts derived from IGKC and IGHG2 correlated with immunogenicity. Notably, using an independent dataset, the expression of glucosamine (N-acetyl)-6-sulfatase was found to reproducibly correlate with the magnitude of immune response. Transcriptomic and flow cytometric data revealed depletion of switched memory B cells following plain-polysaccharide vaccine.</p> <h4>Conclusions</h4> <p>These data describe distinct gene signatures associated with the production of high-avidity antibody and a plain-polysaccharide-specific signature, possibly linked to polysaccharide-induced hyporesponsiveness.</p>
spellingShingle O'Connor, D
Clutterbuck, E
Thompson, A
Snape, M
Ramasamy, M
Kelly, D
Pollard, A
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title_full High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title_fullStr High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title_full_unstemmed High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title_short High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
title_sort high dimensional assessment of b cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine
work_keys_str_mv AT oconnord highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT clutterbucke highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT thompsona highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT snapem highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT ramasamym highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT kellyd highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine
AT pollarda highdimensionalassessmentofbcellresponsestoquadrivalentmeningococcalconjugateandplainpolysaccharidevaccine